Natural Biocon (India) Management Change
Ms. Shruti Sharma has resigned as Company Secretary and Compliance Officer of Natural Biocon (India) Ltd, effective from 26th September 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Ms. Shruti Sharma has resigned as Company Secretary and Compliance Officer of Natural Biocon (India) Ltd, effective from 26th September 2026.
Natural Biocon approved the Director's report and scheduled its 34th Annual General Meeting for September 30, 2026. It also announced leadership changes, including new director appointments.
Natural Biocon (India) Ltd will hold a board meeting on September 5, 2026, to consider AGM matters and approve various annual reports.
Natural Biocon (India) Ltd reported net profit of ₹0 Cr for Q1 FY27.
Natural Biocon (India) Ltd will hold a board meeting on August 14, 2026. The agenda includes approving quarterly results and appointing new statutory auditors.
Natural Biocon (India) Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026. This is a routine regulatory disclosure of share ownership structure.
Natural Biocon (India) announced the resignation of directors Mrs. Tapasya Sheth and Mrs. Minaben Shah. Both departures are effective from July 14, 2026.
Natural Biocon (India) Limited appointed Ms. Shruti Sharma as Company Secretary and Compliance Officer. This administrative update ensures compliance with regulatory secretarial requirements.
Natural Biocon (India) Limited filed its Annual Secretarial Compliance Report for FY2026. The report lists minor historic late-filing fines and observations regarding secretarial standards and website updates.
Natural Biocon (India) scheduled a board meeting on June 6, 2026. Directors will approve the annual report and fix the AGM date.
Natural Biocon postponed its May 18 board meeting to June 6, 2026, following a medical emergency. Investors should note the revised date for financial approvals.
Natural Biocon (India) Ltd scheduled a board meeting on May 18, 2026. The board will approve AGM details and the FY26 Director's Report.
Natural Biocon (India) Ltd reported revenue from operations of ₹0.9 Cr (-35.7% YoY) and a net loss of ₹0.1 Cr for Q4 FY26.
Natural Biocon (India) Ltd reported a total annual income of ₹2.55 Crore for FY26. The company posted a standalone net loss of ₹0.04 Crore.
Natural Biocon (India) Limited has postponed its Board Meeting originally scheduled for April 30, 2026. The meeting, intended to approve audited financial results for the year ended March 31, 2026, is now rescheduled to May 9, 2026.
Natural Biocon (India) Ltd confirmed it does not meet the SEBI criteria to be classified as a 'Large Corporate' for the financial year. The company reported zero outstanding borrowings as of March 31, 2026. This disclosure is a routine regulatory requirement regarding debt-raising frameworks.
Natural Biocon (India) Ltd has scheduled a Board Meeting on April 30, 2026. The board will consider and approve the audited financial results for the quarter and year ended March 31, 2026, along with related party transactions.